lenalidomide has been researched along with Aphthae in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bessis, D; Cezar, R; Corbeau, P; Poujade, L; Samaran, Q; Sarrabay, G; Tran, TA | 1 |
| Antonioli, E; Guglielmelli, P; Loscocco, GG; Mannelli, F; Romano, I; Rotunno, G; Vannucchi, AM; Vergoni, F | 1 |
| de la Varga-Martínez, R; Jiménez-Gallo, D; Linares-Barrios, M; Ossorio-García, L | 1 |
| Kalampokis, I; Rabinovich, CE | 1 |
4 other study(ies) available for lenalidomide and Aphthae
| Article | Year |
|---|---|
Lenalidomide for treatment of refractory aphthosis and neutrophilic pustulosis in familial pyrin-associated autoinflammation with neutrophilic dermatosis.
Topics: Dermatitis; Humans; Lenalidomide; Neutrophils; Pyoderma Gangrenosum; Pyrin; Stomatitis, Aphthous | 2023 |
Lenalidomide: A double-edged sword for concomitant multiple myeloma and post-essential thrombocythemia myelofibrosis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aspirin; Bone Marrow; Calreticulin; Dexamethasone; Humans; Hydroxyurea; Lenalidomide; Male; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Osteolysis; Primary Myelofibrosis; Remission Induction; Risk Factors; Sequence Deletion; Stomatitis, Aphthous; Thrombocythemia, Essential | 2021 |
Lenalidomide for treatment of recurrent oral aphthae in Adamantiades-Behçet's disease.
Topics: Adult; Angiogenesis Inhibitors; Behcet Syndrome; Female; Humans; Lenalidomide; Stomatitis, Aphthous | 2018 |
Successful management of refractory pediatric-onset complex aphthosis with lenalidomide.
Topics: Adolescent; Diagnosis, Differential; Humans; Immunologic Factors; Lenalidomide; Male; Recurrence; Stomatitis, Aphthous; Thalidomide | 2014 |